Zheng Zhang

发表

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Zhaohui Zheng, J. Miao, Jun Zhang, 2020, bioRxiv.

Multidimensional Integration Analysis of Autophagy-related Modules in Colorectal Cancer

Jianzhen Xu, Yanhui Li, Huihui Fan, 2019, Letters in Organic Chemistry.

Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice.

Y. Li, Qiang Zhang, Chung Lee, 2008, Cancer letters.

Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus

J. Xing, J. Xu, P. Zhu, 2005, The Journal of infectious diseases.

Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum

P. Zhu, Zheng Zhang, H. Bian, 2020, Acta pharmaceutica Sinica. B.

New strategy for large-scale preparation of the extracellular domain of tumor-associated antigen HAb18G/CD147 (HAb18GED).

Hushan Yang, Y. Li, J. Xing, 2011, Journal of bioscience and bioengineering.

Biodistribution and localization of iodine-131 labeled metuximab in patients with hepatocellular carcinoma

Min Zhang, Yang Zhang, P. Zhu, 2006, Cancer Biology & Therapy.

CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis

Zhaohui Zheng, Ke Wang, Zheng Zhang, 2022, Signal Transduction and Targeted Therapy.

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Yang Zhang, Zhaohui Zheng, J. Miao, 2020 .

Immunological and metabolic characteristics of the Omicron variants infection

Guizhen Wu, Tao Zhang, Youchun Wang, 2023, Signal Transduction and Targeted Therapy.

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Zhaohui Zheng, J. Miao, A. Wen, 2021, Signal Transduction and Targeted Therapy.

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

Yang Zhang, Xi Ma, Zheng Zhang, 2015, Molecular Cancer.

Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma

Hushan Yang, Zheng Zhang, H. Bian, 2010, Journal of cellular and molecular medicine.

HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection

Jing Xu, Yang Zhang, Wei-De Zhong, 2009, Histopathology.

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Zhaohui Zheng, J. Miao, Jun Zhang, 2020, Signal Transduction and Targeted Therapy.

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A

Zheng Zhang, H. Bian, J. Cui, 2018, Journal of immunology research.

Expression of CD147 is associated with prostate cancer progression

Chin-Lee Wu, W. Zhong, Zheng Zhang, 2012, International journal of cancer.

Expression levels of transcription factors c-Fos and c-Jun and transmembrane protein HAb18G/CD147 in urothelial carcinoma of the bladder

Yang Zhang, Yang Zhang, Zheng Zhang, 2017, Molecular medicine reports.

Preclinical Pharmacokinetics, Tolerability, and Pharmacodynamics of Metuzumab, a Novel CD147 Human–Mouse Chimeric and Glycoengineered Antibody

Yang Zhang, Qian Sun, Zheng Zhang, 2014, Molecular Cancer Therapeutics.

Crystal Structure of HAb18G/CD147

Ning Wen, Jian Zhang, Xu Shen, 2008, Journal of Biological Chemistry.

Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma

Yang Zhang, Zheng Zhang, Bin Wang, 2017, Cancer biology & therapy.

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma

Guizhen Wu, Zhaohui Zheng, J. Miao, 2021, Signal Transduction and Targeted Therapy.

Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors.

Hushan Yang, J. Xing, Zhi-nan Chen, 2012, Carcinogenesis.

For Peer Review Hypoxia upregulates CD147 through a combined effect of HIF1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors

Hushan Yang, J. Xing, Zhi-nan Chen, 2012 .

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

Ping Zhu, Gang Nan, Ronghua Xie, 2020, medRxiv.

A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

Ping Zhu, Jing Xu, P. Zhu, 2007, Hepatology.

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 variants

Guizhen Wu, Zhaohui Zheng, Jun Zhang, 2021, bioRxiv.

Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.

Jing Xu, Ping Zhu, Nan Leng, 2006, International journal of radiation oncology, biology, physics.

[Expression and significance of CD147 protein in prostate cancer].

Yang Zhang, J. Zou, W. Zhong, 2009, Zhonghua yi xue za zhi.

Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

S. Hamid, Zhaohui Zheng, J. Miao, 2023, Signal Transduction and Targeted Therapy.

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma

Yang Zhang, Xi Ma, Zheng Zhang, 2015, Molecular Cancer.

Crystal Structure of HAb18G/CD147

Jian Zhang, Hualiang Jiang, Xu Shen, 2008, Journal of Biological Chemistry.